HSP 56, more commonly identified as FKBP4 or FK506 binding protein 4, belongs to the immunophilin protein family. As its name suggests, FKBP4 has a natural affinity for certain immunosuppressants, notably tacrolimus (FK506) and sirolimus (rapamycin). The binding of these compounds to FKBP4 can steer various cellular processes, particularly by altering calcium signaling dynamics and influencing pathways tied to mTOR (mammalian target of rapamycin). Tacrolimus, as a notable example, binds directly to FKBP4, leading to effects on calcium-dependent signaling pathways. Similarly, sirolimus, by attaching to FKBP4, primarily operates as an inhibitor of mTOR, a pivotal component in cell growth, proliferation, and survival.
Ascomycin and pimecrolimus, although distinct in their structures, can also bind to FKBP4, influencing T-cell activation and calcium signaling pathways. Everolimus, zotarolimus, temsirolimus, and ridaforolimus are further examples of chemicals in this category, each being an mTOR inhibitor that demonstrates an affinity for FKBP4. On a different spectrum, agents like geldanamycin, radicicol, and celastrol can affect the broader heat shock protein response. While not direct binders to FKBP4, their modulation of the heat shock protein landscape suggests they can have some bearing on FKBP4 activity, given the latter's membership in the heat shock protein family.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
An immunosuppressant drug that binds to FKBP4 and influences calcium signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to FKBP4 and acts primarily by inhibiting mTOR (mammalian target of rapamycin). | ||||||
Ascomycin | 104987-12-4 | sc-207303B sc-207303 sc-207303A | 1 mg 5 mg 25 mg | $37.00 $176.00 $322.00 | ||
An immunosuppressant that can bind to FKBP4 and impact calcium signaling pathways. | ||||||
Pimecrolimus | 137071-32-0 | sc-208172 | 1 mg | $140.00 | 2 | |
An immunomodulating agent that binds to FKBP4 and affects T-cell activation. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
An inhibitor of mTOR that binds to FKBP4. | ||||||
Zotarolimus | 221877-54-9 | sc-213188 | 1 mg | $240.00 | ||
An mTOR inhibitor and rapamycin analog that binds to FKBP4. | ||||||
Ridaforolimus | 572924-54-0 | sc-212783 | 5 mg | $248.00 | 1 | |
A mTOR inhibitor that binds to FKBP4. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Another agent that affects the heat shock response and can indirectly impact FKBP4. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
A natural triterpenoid that can affect the heat shock response and may have an indirect influence on FKBP4. | ||||||